āagmanLoginNot investment advice. Data and computed figures, for information only.
Dr Agarwals Health Care Ltd
₹465.80
−₹11.35 (−2.38%)
NSE · 16 Oct 2026, close
Market Cap
₹15,851 Cr
CMP
₹465.80
52-wk High / Low
₹568 / 401
P/E
107.0
P/B
7.8
Book Value
₹63.9
Div Yield
0.00%
ROCE
11.0%
ROE
6.0%
Face Value
₹1
D/E
0.53
Price−10.3% over 1Y
āagman read
Computed by āagmanPiotroski F-Score
7
/ 9
7 of 9 F-score tests passed
Graham Number
₹78
√(22.5 × EPS × book value per share)
ROIC
6.6%
vs 11.2% sector median
Cash flow to profit
3.09
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+140
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
6.0%
ROE × earnings retention ratio
ROE stability
5.7
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom −0.01FII +0.03DII −0.11
Latest quarter vs the previous one
Cash-accrual divergence
−9.2%
of assets
Low = accruals track cash flow
Strengths
+Piotroski F-Score of 7/9 is in the strong band (≥7)
Watch-outs
−Latest ROCE of 11% trails the sector median of 17%
−Price trades below its 200-day moving average (1.0x)
Peer comparison
| Name | P/E | Mar Cap ₹ Cr | ROCE % | ROE % |
|---|
Quarterly results
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 333 | 349 | 403 | 417 | 431 | 460 | 487 | 499 | 530 | 564 | 614 |
| Expenses | 244 | 241 | 300 | 310 | 316 | 329 | 360 | 363 | 386 | 403 | 444 |
| Operating Profit | 89 | 108 | 104 | 107 | 115 | 131 | 128 | 136 | 144 | 161 | 170 |
| OPM % | 26.7% | 30.9% | 25.8% | 25.7% | 26.7% | 28.5% | 26.3% | 27.3% | 27.2% | 28.5% | 27.7% |
| Other Income | 12 | 20 | 6 | 12 | 13 | 13 | 13 | 8 | 11 | 14 | 6 |
| Interest | 22 | 27 | 27 | 28 | 28 | 25 | 25 | 23 | 21 | 22 | 23 |
| Depreciation | 43 | 47 | 56 | 57 | 58 | 60 | 63 | 68 | 69 | 77 | 78 |
| Profit before tax | 36 | 54 | 27 | 33 | 41 | 59 | 54 | 54 | 65 | 77 | 75 |
| Net Profit | 23 | 41 | 18 | 21 | 28 | 43 | 38 | 36 | 44 | 50 | 55 |
| EPS (₹) | — | — | — | — | 0.72 | 1.03 | 0.95 | 0.94 | 1.07 | 1.25 | 1.43 |
Profit & Loss
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 531 | 471 | 696 | 1,018 | 1,332 | 1,711 | 2,080 | 2,207 |
| Expenses | 407 | 387 | 510 | 743 | 965 | 1,248 | 1,503 | 1,595 |
| Operating Profit | 124 | 85 | 186 | 275 | 367 | 463 | 577 | 612 |
| OPM % | 23.4% | 18.0% | 26.7% | 27.0% | 27.6% | 27.1% | 27.7% | 27.7% |
| Other Income | 13 | 6 | 17 | 14 | 44 | 43 | 46 | 39 |
| Interest | 54 | 44 | 49 | 76 | 101 | 115 | 98 | 89 |
| Depreciation | 93 | 95 | 98 | 128 | 170 | 231 | 276 | 292 |
| Profit before tax | −11 | −48 | 57 | 84 | 141 | 160 | 249 | 270 |
| Net Profit | −21 | −59 | 43 | 103 | 95 | 110 | 168 | 185 |
| EPS (₹) | — | — | — | — | — | 2.64 | 4.20 | 4.69 |
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 8 | 9 | 32 | 32 | — |
| Reserves | 242 | 177 | 206 | 622 | 1,330 | 1,835 | 1,994 | — |
| Borrowings | 162 | 185 | 633 | 857 | 966 | 961 | 1,066 | — |
| Other Liabilities | 339 | 417 | 179 | 336 | 445 | 837 | 849 | — |
| Total Liabilities | 751 | 787 | 1,025 | 1,823 | 2,751 | 3,665 | 3,941 | — |
| Fixed Assets | 551 | 575 | 701 | 1,293 | 1,746 | 2,523 | 2,870 | — |
| CWIP | 8 | 11 | 28 | 99 | 118 | 153 | 244 | — |
| Investments | 1 | 0 | 0 | 34 | 471 | 264 | 152 | — |
| Other Assets | 192 | 201 | 295 | 397 | 416 | 724 | 675 | — |
| Total Assets | 751 | 787 | 1,025 | 1,823 | 2,751 | 3,665 | 3,941 | — |
Cash Flows
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 103 | 99 | 164 | 233 | 346 | 357 | 519 |
| Cash from Investing Activity | −85 | −46 | −155 | −509 | −914 | −750 | −308 |
| Cash from Financing Activity | −73 | −37 | 35 | 303 | 553 | 382 | −220 |
| Net Cash Flow | −56 | 17 | 44 | 27 | −15 | −11 | −10 |
Ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| ROCE % | — | −1.0 | 17.0 | 13.0 | 11.0 | 10.0 | 11.0 |
| ROE % | — | — | — | — | — | — | 6.0 |
| EPS (₹) | — | — | — | — | — | 2.64 | 4.20 |
| Book Value (₹) | — | — | — | — | — | — | 63.9 |
| Face Value (₹) | — | — | — | — | — | — | 1 |
| P/E | — | — | — | — | — | — | 107.0 |
| Div Yield % | — | — | — | — | — | — | 0.00 |
| NPM % | −3.9 | −12.4 | 6.0 | 10.0 | 6.9 | 6.3 | 7.9 |
| OPM % | 23.0 | 18.0 | 27.0 | 27.0 | 28.0 | 27.0 | 28.0 |
| D/E | 0.65 | 1.01 | 2.97 | 1.36 | 0.72 | 0.51 | 0.53 |
| P/B | — | — | — | — | — | — | 7.8 |
Growth
Compounded sales growth
5 years+35.0%
3 years+27.0%
TTM+23.0%
Compounded profit growth
5 years+33.0%
3 years+9.0%
TTM+43.0%
Stock price CAGR
Last year+2.0%
Return on equity
5 years7.0%
3 years6.0%
Last year6.0%
Documents
Announcements
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportShareholder Meeting / Postal Ballot-Outcome of AGMAnnouncement under Regulation 30 (LODR)-Newspaper PublicationReg. 34 (1) Annual Report.Sixteenth Annual General Meeting Of Dr Agarwals Health Care Limited To Be Held On September 21, 2026Corporate actions
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman